JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 10 1848-1850
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lakshmanan, M.
Right arrow Articles by Robbins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lakshmanan, M.
Right arrow Articles by Robbins, J.

Pelvic Radioiodine Uptake in a Rectal Wall Teratoma After Thyroidectomy for Papillary Carcinoma

Mark Lakshmanan*, James C. Reynolds, Silvana Del Vecchio, Maria J. Merino, Jeffrey A. Norton and Jacob Robbins

Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Nuclear Medicine Department, Warren Grant Magnuson Clinical Center, NIH
Laboratory of Pathology and Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland
Istituto Medicina Nucleare, II Facolta Di Med. E. Chir., Naples, Italy

Correspondence: For reprints contact: Dr. Jacob Robbins, CEB/NIDDK, NIH, 9000 Rockville Pike, Bethesda, MD 20892.

ABSTRACT

A 30-yr-old woman with previously resected papillary thyroid carcinoma was found to have a pelvic lesion which concentrated radioiodine. By performing simultaneous 131I whole-body and 99mTc-methylene diphosphonate bone scans, we found the lesion to be in soft tissue between the sacrum and bladder. Radioiodine therapy was postponed so that the lesion, a benign teratoma of the rectal wall, could be surgically removed. Prior to laparotomy, the patient received a second tracer dose of 131I so that the lesion could be located at surgery with a hand-held gamma detector. A postoperative whole-body 131I scan confirmed that the lesion had been removed, thus reducing the absorbed radiation that would have been received by the ovaries during radioiodine therapy. Although the lesion contained both thyroid and gastric epithelium, accumulated 131I was limited to the area with thyroid follicles.

FOOTNOTES

* Current address: Departments of Medicine and Physiology and Biophysics, School of Medicine, CWRU.

Disclaimer: The opinions or assertions of this publication are the private views of the authors and are not to be construed as official or reflecting the views of the U.S. Government, nor does mention of trade names or commercial products imply endorsement by the U.S. Government.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
N Nair, S Basu, and H Pakhale
Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma
Br. J. Radiol., January 1, 2004; 77(913): 63 - 67.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.